4-methoxyamphetamine has been researched along with albuterol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bralet, J; Rochette, L; Tannière-Zeller, M | 1 |
| Abramson, MJ; Elliot, JG; James, AL; Walters, EH | 1 |
| Kuehn, BM | 1 |
3 other study(ies) available for 4-methoxyamphetamine and albuterol
| Article | Year |
|---|---|
PAF-acether-induced mortality in mice: protection by benzodiazepines.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Benzodiazepines; Cattle; Death; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mice; Plant Extracts; Platelet Activating Factor; Pyrilamine; Triazoles | 1989 |
Time to death, airway wall inflammation and remodelling in fatal asthma.
Topics: Adolescent; Adult; Albuterol; Asthma; Bronchodilator Agents; Death; Female; Humans; Lung; Male; Mucus; Muscle Contraction; Muscle, Smooth; Respiratory Mucosa; Time Factors | 2005 |
FDA panel: ban 2 popular asthma drugs.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Advisory Committees; Albuterol; Androstadienes; Anti-Asthmatic Agents; Bronchodilator Agents; Budesonide; Death; Drug Approval; Drug Combinations; Ethanolamines; Fluticasone; Formoterol Fumarate; Humans; Marketing of Health Services; Salmeterol Xinafoate; United States; United States Food and Drug Administration | 2009 |